Paper · 29928801
Understanding the Interplay between Self-Assembling Peptides and Solution Ions for Tunable Protein Nanoparticle Formation.
Shanbhag BK and 3 others. ACS Nano, 2018. Cited by 23 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Understanding the Interplay between Self-Assembling Peptides and Solution Ions for Tunable Protein Nanoparticle Formation. Papers, record 29928801. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29928801
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Understanding the Interplay between Self-Assembling Peptides and Solution Ions for Tunable Protein Nanoparticle Formation.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanoparticles | Major topic |
| Peptides | Major topic |
| Proteins | Major topic |
| Ions | |
| Models, Molecular | |
| Molecular Structure | |
| Particle Size | |
| Solutions | |
| Surface Properties |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,039,269 | Self-assembled nanoplatforms for cancer immunotherapy: Principles, progress and perspectives. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42039269 | PubMed |
| 41,575,319 | Identification of Novel Growth Factor Conjugated Nanofibers for Stimulation of Neuronal Growth. | Macromol Biosci | 2026 | https://conductscience.org/library/papers/41575319 | PubMed |
| 41,470,951 | Sodium Dodecylbenzene Sulfonate-Mediated Self-Assembly of Silk Particles from Formic Acid Solutions into Robust Films. | Polymers (Basel) | 2025 | https://conductscience.org/library/papers/41470951 | PubMed |
| 40,772,702 | Optimizing Silk Nanoparticle Assembly with Potassium Ions: Effects on Physicochemical Properties and Encapsulation Efficiency. | ACS Appl Bio Mater | 2025 | https://conductscience.org/library/papers/40772702 | PubMed |
| 40,353,600 | Protein nanocages: A new frontier in mucosal vaccine delivery and immune activation. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/40353600 | PubMed |
| 36,895,553 | Self-assembled nanoparticles: A new platform for revolutionizing therapeutic cancer vaccines. | Front Immunol | 2023 | https://conductscience.org/library/papers/36895553 | PubMed |
| 36,132,345 | Sound methods for the synthesis of nanoparticles from biological molecules. | Nanoscale Adv | 2021 | https://conductscience.org/library/papers/36132345 | PubMed |
| 35,487,503 | Engineering Self-Assembling Protein Nanoparticles for Therapeutic Delivery. | Bioconjug Chem | 2022 | https://conductscience.org/library/papers/35487503 | PubMed |
| 34,267,794 | Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy. | Nano Today | 2021 | https://conductscience.org/library/papers/34267794 | PubMed |
| 32,911,613 | Sono-Assembly of the [Arg-Phe]4 Octapeptide into Biofunctional Nanoparticles. | Nanomaterials (Basel) | 2020 | https://conductscience.org/library/papers/32911613 | PubMed |
1 to 10 of 11
See all 11 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29928801
GET https://conductscience.org/api/papers/v1/29928801/authors